It is now more than 7 months into the pandemic in the US and doctors and scientists have been trying pretty much everything with little to show. Perhaps the most effort has gone into finding drugs to prevent the immune system meltdown caused by the virus. Here's another. Can a simple, safe, approved drug called phenylbutyric acid tread the line between under- and over-treatment of the immune system by reducing cell stress?
Long ago, roughly 100 years past, in a place far away, there were few (if any) effective treatments for pneumonia. One treatment that seemed to help was targeting the lungs with low-dose radiation. Could COVID-19’s attack on the lungs be stopped in a similar way? Several small studies are now underway to find out.
At first glance, rheumatoid arthritis and coronavirus have little in common. But an underlying pathological mechanism that involves an over-reactive immune response may allow a drug developed to treat arthritis to save the lives of coronavirus victims.
We have yet another tragic flu story in the news. This time it's a 38-year old mother who died because she thought the flu drug she was prescribed was too expensive. The only problem? The media got everything wrong. The flu drug would not have made any difference.